Special groups

Can Spinal Muscular Atrophy Be Screened by IVF in Kyrgyzstan? - Genetic Disease PGT Testing Guide

Spinal Muscular Atrophy (SMA) can be screened through PGT-M technology for embryos. Some reproductive centers in Kyrgyzstan have the capability for single-gene disease testing, but laboratory qualifications, carrier genetic reports, and genetic counseling processes need evaluation. This article details SMA screening conditions, technical pathways, procedures, and precautions.

Read More

Can third-generation IVF in Kyrgyzstan screen for genetic diseases? Scope and limitations of PGT technology

Third-generation IVF (PGT) in Kyrgyzstan can screen for chromosomal numerical abnormalities, structural abnormalities, and some monogenic genetic diseases. The screening scope is limited by the completeness of genetic counseling, laboratory testing platforms, and embryo biopsy techniques. Not all genetic diseases can be detected by PGT; a comprehensive assessment based on the specific disease, pedigree analysis, and testing plan is required.

Read More

Factors Influencing IVF Success Rates for Polycystic Ovary Syndrome in Kyrgyzstan

For patients with Polycystic Ovary Syndrome (PCOS) undergoing IVF in Kyrgyzstan, success rates are influenced by a combination of factors including age, endocrine control, insulin resistance, stimulation protocols, and embryo quality. This article outlines key preparations, procedures, risks, and considerations for PCOS patients seeking overseas IVF to help make informed decisions.

Read More